ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Daunorubicin Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-2K8212
Home | Market Reports | Health| Health Conditions| Cancer
Global Daunorubicin Market Insights and Forecast to 2028
BUY CHAPTERS

Global Daunorubicin Market Research Report 2025

Code: QYRE-Auto-2K8212
Report
July 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
Halison Pharmaceuiticals
Hikma Pharmaceuticals
Gilead Sciences
Bedford Pharmaceuticals
United Biotech
Mercian Corporation
Pharmacia
Cipla Ltd
TEVA
Medior Healthcare
West-Ward
Shandong Xinshidai Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical

Daunorubicin Market

The global market for Daunorubicin was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Daunorubicin is mainly used for acute lymphocytic or myelogenous leukemia resistant to common anti-tumor drugs, but the remission period is short, so it needs to be combined with other drugs.It is orange-red acicular crystal, easily soluble in water.Its aqueous solution is quite stable and can be kept at 0℃ or 37℃ for 3 weeks without changing its activity.The effect is the same as adriamycin, embedded DNA, can inhibit the synthesis of RNA and DNA, the effect on RNA is particularly obvious, selective effect on purine nucleoside.
North American market for Daunorubicin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Daunorubicin is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Daunorubicin include Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, Bedford Pharmaceuticals, United Biotech, Mercian Corporation, Pharmacia, Cipla, TEVA, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Daunorubicin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Daunorubicin.
The Daunorubicin market size, estimations, and forecasts are provided in terms of sales volume (Litre) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Daunorubicin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Daunorubicin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Daunorubicin Market Report

Report Metric Details
Report Name Daunorubicin Market
Segment by Type
  • Intravenous
  • Drip
Segment by Application
  • Acute Granulocyte
  • Acute Lymphocyte Leukemia
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, Bedford Pharmaceuticals, United Biotech, Mercian Corporation, Pharmacia, Cipla, TEVA, Medior Healthcare, West-Ward, Shandong Xinshidai Pharmaceutical, HISUN, Shenzhen Wanle Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Daunorubicin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Daunorubicin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Daunorubicin Market report?

Ans: The main players in the Daunorubicin Market are Sanofi, Halison Pharmaceuiticals, Hikma Pharmaceuticals, Gilead Sciences, Bedford Pharmaceuticals, United Biotech, Mercian Corporation, Pharmacia, Cipla, TEVA, Medior Healthcare, West-Ward, Shandong Xinshidai Pharmaceutical, HISUN, Shenzhen Wanle Pharmaceutical

What are the Application segmentation covered in the Daunorubicin Market report?

Ans: The Applications covered in the Daunorubicin Market report are Acute Granulocyte, Acute Lymphocyte Leukemia

What are the Type segmentation covered in the Daunorubicin Market report?

Ans: The Types covered in the Daunorubicin Market report are Intravenous, Drip

1 Daunorubicin Market Overview
1.1 Product Definition
1.2 Daunorubicin by Type
1.2.1 Global Daunorubicin Market Value Comparison by Type (2024 VS 2031)
1.2.2 Intravenous
1.2.3 Drip
1.3 Daunorubicin by Application
1.3.1 Global Daunorubicin Market Value by Application (2024 VS 2031)
1.3.2 Acute Granulocyte
1.3.3 Acute Lymphocyte Leukemia
1.4 Global Daunorubicin Market Size Estimates and Forecasts
1.4.1 Global Daunorubicin Revenue 2020-2031
1.4.2 Global Daunorubicin Sales 2020-2031
1.4.3 Global Daunorubicin Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Daunorubicin Market Competition by Manufacturers
2.1 Global Daunorubicin Sales Market Share by Manufacturers (2020-2025)
2.2 Global Daunorubicin Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Daunorubicin Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Daunorubicin, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Daunorubicin, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Daunorubicin, Product Type & Application
2.7 Global Key Manufacturers of Daunorubicin, Date of Enter into This Industry
2.8 Global Daunorubicin Market Competitive Situation and Trends
2.8.1 Global Daunorubicin Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Daunorubicin Players Market Share by Revenue
2.8.3 Global Daunorubicin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Daunorubicin Market Scenario by Region
3.1 Global Daunorubicin Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Daunorubicin Sales by Region: 2020-2031
3.2.1 Global Daunorubicin Sales by Region: 2020-2025
3.2.2 Global Daunorubicin Sales by Region: 2026-2031
3.3 Global Daunorubicin Revenue by Region: 2020-2031
3.3.1 Global Daunorubicin Revenue by Region: 2020-2025
3.3.2 Global Daunorubicin Revenue by Region: 2026-2031
3.4 North America Daunorubicin Market Facts & Figures by Country
3.4.1 North America Daunorubicin Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Daunorubicin Sales by Country (2020-2031)
3.4.3 North America Daunorubicin Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Daunorubicin Market Facts & Figures by Country
3.5.1 Europe Daunorubicin Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Daunorubicin Sales by Country (2020-2031)
3.5.3 Europe Daunorubicin Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Daunorubicin Market Facts & Figures by Region
3.6.1 Asia Pacific Daunorubicin Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Daunorubicin Sales by Region (2020-2031)
3.6.3 Asia Pacific Daunorubicin Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Daunorubicin Market Facts & Figures by Country
3.7.1 Latin America Daunorubicin Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Daunorubicin Sales by Country (2020-2031)
3.7.3 Latin America Daunorubicin Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Daunorubicin Market Facts & Figures by Country
3.8.1 Middle East and Africa Daunorubicin Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Daunorubicin Sales by Country (2020-2031)
3.8.3 Middle East and Africa Daunorubicin Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Daunorubicin Sales by Type (2020-2031)
4.1.1 Global Daunorubicin Sales by Type (2020-2025)
4.1.2 Global Daunorubicin Sales by Type (2026-2031)
4.1.3 Global Daunorubicin Sales Market Share by Type (2020-2031)
4.2 Global Daunorubicin Revenue by Type (2020-2031)
4.2.1 Global Daunorubicin Revenue by Type (2020-2025)
4.2.2 Global Daunorubicin Revenue by Type (2026-2031)
4.2.3 Global Daunorubicin Revenue Market Share by Type (2020-2031)
4.3 Global Daunorubicin Price by Type (2020-2031)
5 Segment by Application
5.1 Global Daunorubicin Sales by Application (2020-2031)
5.1.1 Global Daunorubicin Sales by Application (2020-2025)
5.1.2 Global Daunorubicin Sales by Application (2026-2031)
5.1.3 Global Daunorubicin Sales Market Share by Application (2020-2031)
5.2 Global Daunorubicin Revenue by Application (2020-2031)
5.2.1 Global Daunorubicin Revenue by Application (2020-2025)
5.2.2 Global Daunorubicin Revenue by Application (2026-2031)
5.2.3 Global Daunorubicin Revenue Market Share by Application (2020-2031)
5.3 Global Daunorubicin Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Company Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Sanofi Daunorubicin Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Halison Pharmaceuiticals
6.2.1 Halison Pharmaceuiticals Company Information
6.2.2 Halison Pharmaceuiticals Description and Business Overview
6.2.3 Halison Pharmaceuiticals Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Halison Pharmaceuiticals Daunorubicin Product Portfolio
6.2.5 Halison Pharmaceuiticals Recent Developments/Updates
6.3 Hikma Pharmaceuticals
6.3.1 Hikma Pharmaceuticals Company Information
6.3.2 Hikma Pharmaceuticals Description and Business Overview
6.3.3 Hikma Pharmaceuticals Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hikma Pharmaceuticals Daunorubicin Product Portfolio
6.3.5 Hikma Pharmaceuticals Recent Developments/Updates
6.4 Gilead Sciences
6.4.1 Gilead Sciences Company Information
6.4.2 Gilead Sciences Description and Business Overview
6.4.3 Gilead Sciences Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Gilead Sciences Daunorubicin Product Portfolio
6.4.5 Gilead Sciences Recent Developments/Updates
6.5 Bedford Pharmaceuticals
6.5.1 Bedford Pharmaceuticals Company Information
6.5.2 Bedford Pharmaceuticals Description and Business Overview
6.5.3 Bedford Pharmaceuticals Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bedford Pharmaceuticals Daunorubicin Product Portfolio
6.5.5 Bedford Pharmaceuticals Recent Developments/Updates
6.6 United Biotech
6.6.1 United Biotech Company Information
6.6.2 United Biotech Description and Business Overview
6.6.3 United Biotech Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.6.4 United Biotech Daunorubicin Product Portfolio
6.6.5 United Biotech Recent Developments/Updates
6.7 Mercian Corporation
6.7.1 Mercian Corporation Company Information
6.7.2 Mercian Corporation Description and Business Overview
6.7.3 Mercian Corporation Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mercian Corporation Daunorubicin Product Portfolio
6.7.5 Mercian Corporation Recent Developments/Updates
6.8 Pharmacia
6.8.1 Pharmacia Company Information
6.8.2 Pharmacia Description and Business Overview
6.8.3 Pharmacia Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pharmacia Daunorubicin Product Portfolio
6.8.5 Pharmacia Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Company Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Cipla Daunorubicin Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 TEVA
6.10.1 TEVA Company Information
6.10.2 TEVA Description and Business Overview
6.10.3 TEVA Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.10.4 TEVA Daunorubicin Product Portfolio
6.10.5 TEVA Recent Developments/Updates
6.11 Medior Healthcare
6.11.1 Medior Healthcare Company Information
6.11.2 Medior Healthcare Description and Business Overview
6.11.3 Medior Healthcare Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Medior Healthcare Daunorubicin Product Portfolio
6.11.5 Medior Healthcare Recent Developments/Updates
6.12 West-Ward
6.12.1 West-Ward Company Information
6.12.2 West-Ward Description and Business Overview
6.12.3 West-Ward Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.12.4 West-Ward Daunorubicin Product Portfolio
6.12.5 West-Ward Recent Developments/Updates
6.13 Shandong Xinshidai Pharmaceutical
6.13.1 Shandong Xinshidai Pharmaceutical Company Information
6.13.2 Shandong Xinshidai Pharmaceutical Description and Business Overview
6.13.3 Shandong Xinshidai Pharmaceutical Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shandong Xinshidai Pharmaceutical Daunorubicin Product Portfolio
6.13.5 Shandong Xinshidai Pharmaceutical Recent Developments/Updates
6.14 HISUN
6.14.1 HISUN Company Information
6.14.2 HISUN Description and Business Overview
6.14.3 HISUN Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.14.4 HISUN Daunorubicin Product Portfolio
6.14.5 HISUN Recent Developments/Updates
6.15 Shenzhen Wanle Pharmaceutical
6.15.1 Shenzhen Wanle Pharmaceutical Company Information
6.15.2 Shenzhen Wanle Pharmaceutical Description and Business Overview
6.15.3 Shenzhen Wanle Pharmaceutical Daunorubicin Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Shenzhen Wanle Pharmaceutical Daunorubicin Product Portfolio
6.15.5 Shenzhen Wanle Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Daunorubicin Industry Chain Analysis
7.2 Daunorubicin Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Daunorubicin Production Mode & Process Analysis
7.4 Daunorubicin Sales and Marketing
7.4.1 Daunorubicin Sales Channels
7.4.2 Daunorubicin Distributors
7.5 Daunorubicin Customer Analysis
8 Daunorubicin Market Dynamics
8.1 Daunorubicin Industry Trends
8.2 Daunorubicin Market Drivers
8.3 Daunorubicin Market Challenges
8.4 Daunorubicin Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Sanofi
Halison Pharmaceuiticals
Hikma Pharmaceuticals
Gilead Sciences
Bedford Pharmaceuticals
United Biotech
Mercian Corporation
Pharmacia
Cipla Ltd
TEVA
Medior Healthcare
West-Ward
Shandong Xinshidai Pharmaceutical
HISUN
Shenzhen Wanle Pharmaceutical
List of Tables
 Table 1. Global Daunorubicin Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Daunorubicin Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Daunorubicin Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Daunorubicin Sales (Litre) of Key Manufacturers (2020-2025)
 Table 5. Global Daunorubicin Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Daunorubicin Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Daunorubicin Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Daunorubicin Average Price (US$/Litre) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Daunorubicin, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Daunorubicin, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Daunorubicin, Product Type & Application
 Table 12. Global Key Manufacturers of Daunorubicin, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Daunorubicin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Daunorubicin as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Daunorubicin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Daunorubicin Sales by Region (2020-2025) & (Litre)
 Table 18. Global Daunorubicin Sales Market Share by Region (2020-2025)
 Table 19. Global Daunorubicin Sales by Region (2026-2031) & (Litre)
 Table 20. Global Daunorubicin Sales Market Share by Region (2026-2031)
 Table 21. Global Daunorubicin Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Daunorubicin Revenue Market Share by Region (2020-2025)
 Table 23. Global Daunorubicin Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Daunorubicin Revenue Market Share by Region (2026-2031)
 Table 25. North America Daunorubicin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Daunorubicin Sales by Country (2020-2025) & (Litre)
 Table 27. North America Daunorubicin Sales by Country (2026-2031) & (Litre)
 Table 28. North America Daunorubicin Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Daunorubicin Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Daunorubicin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Daunorubicin Sales by Country (2020-2025) & (Litre)
 Table 32. Europe Daunorubicin Sales by Country (2026-2031) & (Litre)
 Table 33. Europe Daunorubicin Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Daunorubicin Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Daunorubicin Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Daunorubicin Sales by Region (2020-2025) & (Litre)
 Table 37. Asia Pacific Daunorubicin Sales by Region (2026-2031) & (Litre)
 Table 38. Asia Pacific Daunorubicin Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Daunorubicin Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Daunorubicin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Daunorubicin Sales by Country (2020-2025) & (Litre)
 Table 42. Latin America Daunorubicin Sales by Country (2026-2031) & (Litre)
 Table 43. Latin America Daunorubicin Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Daunorubicin Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Daunorubicin Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Daunorubicin Sales by Country (2020-2025) & (Litre)
 Table 47. Middle East and Africa Daunorubicin Sales by Country (2026-2031) & (Litre)
 Table 48. Middle East and Africa Daunorubicin Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Daunorubicin Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Daunorubicin Sales (Litre) by Type (2020-2025)
 Table 51. Global Daunorubicin Sales (Litre) by Type (2026-2031)
 Table 52. Global Daunorubicin Sales Market Share by Type (2020-2025)
 Table 53. Global Daunorubicin Sales Market Share by Type (2026-2031)
 Table 54. Global Daunorubicin Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Daunorubicin Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Daunorubicin Revenue Market Share by Type (2020-2025)
 Table 57. Global Daunorubicin Revenue Market Share by Type (2026-2031)
 Table 58. Global Daunorubicin Price (US$/Litre) by Type (2020-2025)
 Table 59. Global Daunorubicin Price (US$/Litre) by Type (2026-2031)
 Table 60. Global Daunorubicin Sales (Litre) by Application (2020-2025)
 Table 61. Global Daunorubicin Sales (Litre) by Application (2026-2031)
 Table 62. Global Daunorubicin Sales Market Share by Application (2020-2025)
 Table 63. Global Daunorubicin Sales Market Share by Application (2026-2031)
 Table 64. Global Daunorubicin Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Daunorubicin Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Daunorubicin Revenue Market Share by Application (2020-2025)
 Table 67. Global Daunorubicin Revenue Market Share by Application (2026-2031)
 Table 68. Global Daunorubicin Price (US$/Litre) by Application (2020-2025)
 Table 69. Global Daunorubicin Price (US$/Litre) by Application (2026-2031)
 Table 70. Sanofi Company Information
 Table 71. Sanofi Description and Business Overview
 Table 72. Sanofi Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 73. Sanofi Daunorubicin Product
 Table 74. Sanofi Recent Developments/Updates
 Table 75. Halison Pharmaceuiticals Company Information
 Table 76. Halison Pharmaceuiticals Description and Business Overview
 Table 77. Halison Pharmaceuiticals Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 78. Halison Pharmaceuiticals Daunorubicin Product
 Table 79. Halison Pharmaceuiticals Recent Developments/Updates
 Table 80. Hikma Pharmaceuticals Company Information
 Table 81. Hikma Pharmaceuticals Description and Business Overview
 Table 82. Hikma Pharmaceuticals Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 83. Hikma Pharmaceuticals Daunorubicin Product
 Table 84. Hikma Pharmaceuticals Recent Developments/Updates
 Table 85. Gilead Sciences Company Information
 Table 86. Gilead Sciences Description and Business Overview
 Table 87. Gilead Sciences Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 88. Gilead Sciences Daunorubicin Product
 Table 89. Gilead Sciences Recent Developments/Updates
 Table 90. Bedford Pharmaceuticals Company Information
 Table 91. Bedford Pharmaceuticals Description and Business Overview
 Table 92. Bedford Pharmaceuticals Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 93. Bedford Pharmaceuticals Daunorubicin Product
 Table 94. Bedford Pharmaceuticals Recent Developments/Updates
 Table 95. United Biotech Company Information
 Table 96. United Biotech Description and Business Overview
 Table 97. United Biotech Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 98. United Biotech Daunorubicin Product
 Table 99. United Biotech Recent Developments/Updates
 Table 100. Mercian Corporation Company Information
 Table 101. Mercian Corporation Description and Business Overview
 Table 102. Mercian Corporation Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 103. Mercian Corporation Daunorubicin Product
 Table 104. Mercian Corporation Recent Developments/Updates
 Table 105. Pharmacia Company Information
 Table 106. Pharmacia Description and Business Overview
 Table 107. Pharmacia Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 108. Pharmacia Daunorubicin Product
 Table 109. Pharmacia Recent Developments/Updates
 Table 110. Cipla Company Information
 Table 111. Cipla Description and Business Overview
 Table 112. Cipla Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 113. Cipla Daunorubicin Product
 Table 114. Cipla Recent Developments/Updates
 Table 115. TEVA Company Information
 Table 116. TEVA Description and Business Overview
 Table 117. TEVA Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 118. TEVA Daunorubicin Product
 Table 119. TEVA Recent Developments/Updates
 Table 120. Medior Healthcare Company Information
 Table 121. Medior Healthcare Description and Business Overview
 Table 122. Medior Healthcare Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 123. Medior Healthcare Daunorubicin Product
 Table 124. Medior Healthcare Recent Developments/Updates
 Table 125. West-Ward Company Information
 Table 126. West-Ward Description and Business Overview
 Table 127. West-Ward Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 128. West-Ward Daunorubicin Product
 Table 129. West-Ward Recent Developments/Updates
 Table 130. Shandong Xinshidai Pharmaceutical Company Information
 Table 131. Shandong Xinshidai Pharmaceutical Description and Business Overview
 Table 132. Shandong Xinshidai Pharmaceutical Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 133. Shandong Xinshidai Pharmaceutical Daunorubicin Product
 Table 134. Shandong Xinshidai Pharmaceutical Recent Developments/Updates
 Table 135. HISUN Company Information
 Table 136. HISUN Description and Business Overview
 Table 137. HISUN Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 138. HISUN Daunorubicin Product
 Table 139. HISUN Recent Developments/Updates
 Table 140. Shenzhen Wanle Pharmaceutical Company Information
 Table 141. Shenzhen Wanle Pharmaceutical Description and Business Overview
 Table 142. Shenzhen Wanle Pharmaceutical Daunorubicin Sales (Litre), Revenue (US$ Million), Price (US$/Litre) and Gross Margin (2020-2025)
 Table 143. Shenzhen Wanle Pharmaceutical Daunorubicin Product
 Table 144. Shenzhen Wanle Pharmaceutical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Daunorubicin Distributors List
 Table 148. Daunorubicin Customers List
 Table 149. Daunorubicin Market Trends
 Table 150. Daunorubicin Market Drivers
 Table 151. Daunorubicin Market Challenges
 Table 152. Daunorubicin Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Daunorubicin
 Figure 2. Global Daunorubicin Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Daunorubicin Market Share by Type: 2024 & 2031
 Figure 4. Intravenous Product Picture
 Figure 5. Drip Product Picture
 Figure 6. Global Daunorubicin Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Daunorubicin Market Share by Application: 2024 & 2031
 Figure 8. Acute Granulocyte
 Figure 9. Acute Lymphocyte Leukemia
 Figure 10. Global Daunorubicin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Daunorubicin Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Daunorubicin Sales (2020-2031) & (Litre)
 Figure 13. Global Daunorubicin Average Price (US$/Litre) & (2020-2031)
 Figure 14. Daunorubicin Report Years Considered
 Figure 15. Daunorubicin Sales Share by Manufacturers in 2024
 Figure 16. Global Daunorubicin Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Daunorubicin Players: Market Share by Revenue in Daunorubicin in 2024
 Figure 18. Daunorubicin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Daunorubicin Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Daunorubicin Sales Market Share by Country (2020-2031)
 Figure 21. North America Daunorubicin Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Daunorubicin Sales Market Share by Country (2020-2031)
 Figure 25. Europe Daunorubicin Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Daunorubicin Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Daunorubicin Revenue Market Share by Region (2020-2031)
 Figure 33. China Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Daunorubicin Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Daunorubicin Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Daunorubicin Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Daunorubicin Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Daunorubicin Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Daunorubicin by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Daunorubicin by Type (2020-2031)
 Figure 55. Global Daunorubicin Price (US$/Litre) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Daunorubicin by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Daunorubicin by Application (2020-2031)
 Figure 58. Global Daunorubicin Price (US$/Litre) by Application (2020-2031)
 Figure 59. Daunorubicin Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global Liposomal Daunorubicin and Cytarabine Market Research Report 2024
Anthracyclines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Daunorubicin Hydrochloride Injection Market Research Report 2025
Global Pirarubicin Market Research Report 2024
Global Idarubicin Hydrochloride for Injection Market Research Report 2024
Global Epirubicin Hydrochloride Market Research Report 2025
Global Dactinomycin Market Research Report 2024
Global Doxorubicin Hydrochloride Injection Market Research Report 2024
Global Doxorubicin Injection Market Research Report 2024
Liposomal Doxorubicin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Idarubicin HCl Market Research Report 2025
Global Idarubicin Hydrochloride Market Research Report 2025
Global Doxifluridine Market Research Report 2024
Cytarabine and Daunorubicin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Doxorubicin Hydrochloride Market Research Report 2024
Cytarabine and Daunorubicin Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vinblastinesulphate Market Research Report 2025
Global Valrubicin Market Research Report 2024
Anthracycline Anticancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vincristine Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions